HCRN Directory

Gynecologic

Phase I trial of pegylated liposomal doxorubicin in combination with BIBF 1120 (nintedanib) in platinum-resistant ovarian cancer

Status

Cancer Types

Gynecologic

Locations

A phase I/II study of topotecan and sorafenib in recurrent, platinum-resistant ovarian cancer

Status

Cancer Types

Gynecologic

Locations

A Phase II, Open-Label, Safety and Efficacy Study of Panzem Nanocrystal Colloidal Dispersion Administered Orally in Patients with Recurrent or Resistant Epithelial Ovarian Cancer

Status

Cancer Types

Gynecologic

Locations

Clinical Activity of Imatinib Mesylate (Gleevec) In Combination with Docetaxel In Patients With Advanced, Platinum-Resistant Ovarian Cancer Or Primary Peritoneal Carcinomatosis

Status

Cancer Types

Gynecologic

Locations

A Phase II Study of Ifosfamide plus Etoposide in Previously treated Ovarian Cancer

Status

Cancer Types

Gynecologic

Locations

Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study

Status

Cancer Types

Gynecologic

Locations

Activity of 2 Methoxyestradiol (Panzem® NCD) in Advanced, Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinomatosis

Status

Cancer Types

Gynecologic

Locations

Imatinib Mesylate in Combination with Docetaxel for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinomatosis

Status

Cancer Types

Gynecologic

Locations

Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: A Phase II Study

Status

Cancer Types

Gynecologic

Locations

Phase II study of ifosfamide plus daily oral etoposide in previously treated ovarian cancer

Status

Cancer Types

Gynecologic

Locations